Controlling lipogenesis and thermogenesis and the use of ergogenic aids for weight control

Novel Food Ingredients for Weight Control

Volumn , Issue , 2007, Pages 58-103

  Palou, A ^a   Bonet, M L ^a  

^a UNIVERSITAT DE LES ILLES BALEARS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84855843985     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1533/9781845693114.1.58     Document Type: Chapter

References (224)

1. Palou A., Serra F., Bonet M.L., Pico C. Obesity: molecular bases of a multifactorial problem. Eur J Nutr 2000, 39:127-144.
2. Palou A., Bonet M.L., Picó C. Study on Obesity and Functional Foods in Europe. The integrated system of body weight control 2002, 40-54. EUROPEAN commission, Directorate General for Research, Luxembourg. A. Palou, M. Bonet, F. Serra (Eds.).
3. Palou A., Pico C., Bonet M.L., Oliver P. The uncoupling protein, thermogenin. Int J Biochem Cell Biol 1998, 30:7-11.
4. Lowell B.B., Spiegelman B.M. Towards a molecular understanding of adaptive thermogenesis. Nature 2000, 404:652-660.
5. Cannon B., Nedergaard J. Brown adipose tissue: function and physiological significance. Physiol Rev 2004, 84:277-359.
6. Lowell B.B., Susulic V.S.V., Hamann A., Lawitts J.A., Himms-Hagen J., Boyer B.B., Kozak L.P., Flier J.S. Development of obesity in transgenic mice after genetic ablation of brown adipose tissue. Nature 1993, 366:740-742.
7. Enerback S., Jacobsson A., Simpson E.M., Guerra C., Yamashita H., Harper M.E., Kozak L.P. Mice lacking mitochondrial uncoupling protein are cold-sensitive but not obese. Nature 1997, 387:90-94.
8. Perseghin G. Pathogenesis of obesity and diabetes mellitus: insights provided by indirect calorimetry in humans. Acta Diabetol 2001, 38:7-21.
9. Cinti S. Adipocyte differentiation and transdifferentiation: plasticity of the adipose organ. J Endocrinol Invest 2002, 25:823-835.
10. Zurlo F., Larson K., Bogardus C., Ravussin E. Skeletal muscle metabolism is a major determinant of resting energy expenditure. J Clin Invest 1990, 86:1423-1427.
11. Ricquier D., Bouillaud F. The uncoupling protein homologues: UCP1, UCP2, UCP3, StUCP and AtUCP. Biochem J 2000, 345(Pt 2):161-179.
12. Ricquier D., Bouillaud F. Mitochondrial uncoupling proteins: from mitochondria to the regulation of energy balance. J Physiol 2000, 529(Pt 1):3-10.
13. Erlanson-Albertsson C. The role of uncoupling proteins in the regulation of metabolism. Acta Physiol Scand 2003, 178:405-412.
14. Weigle D.S., Selfridge L.E., Schwartz M.W., Seeley R.J., Cummings D.E., Havel P.J., Kuijper J.L., Beltrandelrio H. Elevated free fatty acids induce uncoupling protein 3 expression in muscle: a potential explanation for the effect of fasting. Diabetes 1998, 47:298-302.
15. Arsenijevic D., Onuma H., Pecqueur C., Raimbault S., Manning B.S., Miroux B., Couplan E., Alves-Guerra M.C., Goubern M., Surwit R., Bouillaud F., Richard D., Collins S., Ricquier D. Disruption of the uncoupling protein-2 gene in mice reveals a role in immunity and reactive oxygen species production. Nat Genet 2000, 26:435-439.
16. Vidal-Puig A.J., Grujic D., Zhang C.Y., Hagen T., Boss O., Ido Y., Szczepanik A., Wade J., Mootha V., Cortright R., Muoio D.M., Lowell B.B. Energy metabolism in uncoupling protein 3 gene knockout mice. J Biol Chem 2000, 275:16258-16266.
17. Gong D.W., Monemdjou S., Gavrilova O., Leon L.R., Marcussamuels B., Chou C.J., Everett C., Kozak L.P., Li C., Deng C., Harper M.E., Reitman M.L. Lack of obesity and normal response to fasting and thyroid hormone in mice lacking uncoupling protein-3. J Biol Chem 2000, 275:16251-16257.
18. Rolfe D.F., Brown G.C. Cellular energy utilization and molecular origin of standard metabolic rate in mammals. Physiol Rev 1997, 77:731-758.
19. Levine J.A. Non-exercise activity thermogenesis (NEAT). Best Pract Res Clin Endocrinol Metab 2002, 16:679-702.
20. Schrauwen P., Hoeks J., Schaart G., Kornips E., Binas B., Van De Vusse G.J., Van Bilsen M., Luiken J.J., Coort S.L., Glatz J.F., Saris W.H., Hesselink M.K. Uncoupling protein 3 as a mitochondrial fatty acid anion exporter. FASEB J 2003, 17:2272-2274.
21. Schrauwen P., Saris W.H., Hesselink M.K. An alternative function for human uncoupling protein 3: protection of mitochondria against accumulation of nonesterified fatty acids inside the mitochondrial matrix. FASEB J 2001, 15:2497-2502.
22. Himms-Hagen J., Harper M.E. Physiological role of UCP3 may be export of fatty acids from mitochondria when fatty acid oxidation predominates: an hypothesis. Exp Biol Med (Maywood) 2001, 226:78-84.
23. Goglia F., Skulachev V.P. A function for novel uncoupling proteins: antioxidant defense of mitochondrial matrix by translocating fatty acid peroxides from the inner to the outer membrane leaflet. FASEB J 2003, 17:1585-1591.
24. Jezek P., Engstova H., Zackova M., Vercesi A.E., Costa A.D., Arruda P., Garlid K.D. Fatty acid cycling mechanism and mitochondrial uncoupling proteins. Biochim Biophys Acta 1998, 1365:319-327.
25. Skulachev V.P. Uncoupling: new approaches to an old problem of bioenergetics. Biochim Biophys Acta 1998, 1363:100-124.
26. Himms-Hagen J. Brown adipose tissue thermogenesis and obesity. Prog Lipid Res 1989, 28:67-115.
27. Schoeller D.A. The importance of clinical research: the role of thermogenesis in human obesity. Am J Clin Nutr 2001, 73:511-516.
28. Ravussin E., Lillioja S., Anderson T.E., Christin L., Bogardus C. Determinants of 24-hour energy expenditure in man. Methods and results using a respiratory chamber. J Clin Invest 1986, 78:1568-1578.
29. Ravussin E., Lillioja S., Knowler W.C., Christin L., Freymond D., Abbott W.G., Boyce V., Howard B.V., Bogardus C. Reduced rate of energy expenditure as a risk factor for body-weight gain. N Engl J Med 1988, 318:467-472.
30. Levine J.A., Eberhardt N.L., Jensen M.D. Role of nonexercise activity thermogenesis in resistance to fat gain in humans. Science 1999, 283:212-214.
31. Granata G.P., Brandon L.J. The thermic effect of food and obesity: discrepant results and methodological variations. Nutr Rev 2002, 60:223-233.
32. De J.O.N.G.E.L., Bray G.A. The thermic effect of food and obesity: a critical review. Obes Res 1997, 5:622-631.
33. Zurlo F., Lillioja S., Esposito-Del Puente A., Nyomba B.L., Raz I., Saad M.F., Swinburn B.A., Knowler W.C., Bogardus C., Ravussin E. Low ratio of fat to carbohydrate oxidation as predictor of weight gain: study of 24-h RQ. Am J Physiol 1990, 259:E650-657.
34. Treuth M.S., Butte N.F., Sorkin J.D. Predictors of body fat gain in nonobese girls with a familial predisposition to obesity. Am J Clin Nutr 2003, 78:1212-1218.
35. Astrup A., Buemann B., Christensen N.J., Toubro S. Failure to increase lipid oxidation in response to increasing dietary fat content in formerly obese women. Am J Physiol 1994, 266:E592-599.
36. Filozof C.M., Murua C., Sanchez M.P., Brailovsky C., Perman M., Gonzalez C.D., Ravussin E. Low plasma leptin concentration and low rates of fat oxidation in weight-stable post-obese subjects. Obes Res 2000, 8:205-210.
37. Unger R.H. Lipotoxic diseases. Annu Rev Med 2002, 53:319-336.
38. Unger R.H., Orci L. Lipoapoptosis: its mechanism and its diseases. Biochim Biophys Acta 2002, 1585:202-212.
39. Schrauwen P., Hesselink M.K. Oxidative capacity, lipotoxicity, and mitochondrial damage in type 2 diabetes. Diabetes 2004, 53:1412-1417.
40. Yang X., Enerback S., Smith U. Reduced expression of FOXC2 and brown adipogenic genes in human subjects with insulin resistance. Obes Res 2003, 11:1182-1191.
41. Hammarstedt A., Jansson P.A., Wesslau C., Yang X., Smith U. Reduced expression of PGC-1 and insulin-signaling molecules in adipose tissue is associated with insulin resistance. Biochem Biophys Res Commun 2003, 301:578-582.
42. Lowell B.B., Bachman E.S. Beta-adrenergic receptors, diet-induced thermogenesis, and obesity. J Biol Chem 2003, 278:29385-29388.
43. Cannon B., Jacobsson A., Rehnmark S., Nedergaard J. Signal transduction in brown adipose tissue recruitment: noradrenaline and beyond. Int J Obes Relat Metab Disord 1996, 20(Suppl 3):S36-42.
44. Silva J.E. Thyroid hormone control of thermogenesis and energy balance. Thyroid 1995, 5:481-492.
45. Ahima R.S., Flier J.S. Leptin. Annu Rev Physiol 2000, 62:413-437.
46. Halton T.L., Hu F.B. The effects of high protein diets on thermogenesis, satiety and weight loss: a critical review. J Am Coll Nutr 2004, 23:373-385.
47. Study on Obesity and Functional Foods in Europe 2002, European comission, Directorate General for Research, Luxembourg. A. Palou, M.L. Bonet, F. Serra (Eds.).
48. Palou A., Pico C., Bonet M.L. Food safety and functional foods in the European Union: obesity as a paradigmatic example for novel food development. Nutr Rev 2004, 62:S169-181.
49. Petzke K.J., Friedrich M., Metges C.C., Klaus S. Long-term dietary high protein intake up-regulates tissue specific gene expression of uncoupling proteins 1 and 2 in rats. Eur J Nutr 2005, 44:414-421.
50. Reshef L., Olswang Y., Cassuto H., Blum B., Croniger C.M., Kalhan S.C., Tilghman S.M., Hanson R.W. Glyceroneogenesis and the triglyceride/fatty acid cycle. J Biol Chem 2003, 278:30413-30416.
51. Beale E.G., Antoine B., Forest C. Glyceroneogenesis in adipocytes: another textbook case. Trends Biochem Sci 2003, 28:402-403.
52. Beale E.G., Hammer R.E., Antoine B., Forest C. Disregulated glyceroneogenesis: PCK1 as a candidate diabetes and obesity gene. Trends Endocrinol Metab 2004, 15:129-135.
53. Franckhauser S., Munoz S., Pujol A., Casellas A., Riu E., Otaegui P., Su B., Bosch F. Increased fatty acid re-esterification by PEPCK overexpression in adipose tissue leads to obesity without insulin resistance. Diabetes 2002, 51:624-630.
54. Foufelle F., Ferre P. New perspectives in the regulation of hepatic glycolytic and lipogenic genes by insulin and glucose: a role for the transcription factor sterol regulatory element binding protein-1c. Biochem J 2002, 366:377-391.
55. Uyeda K., Yamashita H., Kawaguchi T. Carbohydrate responsive element-binding protein (ChREBP): a key regulator of glucose metabolism and fat storage. Biochem Pharmacol 2002, 63:2075-2080.
56. Towle H.C. Glucose and cAMP: adversaries in the regulation of hepatic gene expression. Proc Natl Acad Sci U S A 2001, 98:13476-13478.
57. Ong J.M., Kern P.A. The role of glucose and glycosylation in the regulation of lipoprotein lipase synthesis and secretion in rat adipocytes. J Biol Chem 1989, 264:3177-3182.
58. Kersten S. Peroxisome proliferator activated receptors and obesity. Eur J Pharmacol 2002, 440:223-234.
59. Rosen E.D., Walkey C.J., Puigserver P., Spiegelman B.M. Transcriptional regulation of adipogenesis. Genes Dev 2000, 14:1293-1307.
60. Yost Y., Jensen D.R., Eckel R.H. Tissue-specific lipoprotein lipase: relationships to body composition and body fat distribution in normal weight humans. Obes Res 1993, 1:1-4.
61. Richelsen B., Pedersen S.B., Moller-Pedersen T., Schmitz O., Moller N., Borglum J.D. Lipoprotein lipase activity in muscle tissue influenced by fatness, fat distribution and insulin in obese females. Eur J Clin Invest 1993, 23:226-233.
62. Jensen D.R., Schlaepfer I.R., Morin C.L., Pennington D.S., Marcell T., Ammon S.M., Gutierrez-Hartmann A., Eckel R.H. Prevention of diet-induced obesity in transgenic mice overexpressing skeletal muscle lipoprotein lipase. Am J Physiol 1997, 273:R683-689.
63. Shepherd P.R., Gnudi L., Tozzo E., Yang H., Leach F., Kahn B.B. Adipose cell hyperplasia and enhanced glucose disposal in transgenic mice overexpressing GLUT4 selectively in adipose tissue. J Biol Chem 1993, 268:22243-22246.
64. Gnudi L., Shepherd P.R., Kahn B.B. Over-expression of GLUT4 selectively in adipose tissue in transgenic mice: implications for nutrient partitioning. Proc Nutr Soc 1996, 55:191-199.
65. Tsao T.S., Stenbit A.E., Li J., Houseknecht K.L., Zierath J.R., Katz E.B., Charron M.J. Muscle-specific transgenic complementation of GLUT4-deficient mice. Effects on glucose but not lipid metabolism. J Clin Invest 1997, 100:671-677.
66. Bergo M., Wu G., Ruge T., Olivecrona T. Down-regulation of adipose tissue lipoprotein lipase during fasting requires that a gene, separate from the lipase gene, is switched on. J Biol Chem 2002, 277:11927-11932.
67. Ong J.M., Kern P.A. Effect of feeding and obesity on lipoprotein lipase activity, immunoreactive protein, and messenger RNA levels in human adipose tissue. J Clin Invest 1989, 84:305-311.
68. Amri E.Z., Teboul L., Vannier C., Grimaldi P.A., Ailhaud G. Fatty acids regulate the expression of lipoprotein lipase gene and activity in preadipose and adipose cells. Biochem J 1996, 314(Pt 2):541-546.
69. Sadur C.N., Yost T.J., Eckel R.H. Fat feeding decreases insulin responsiveness of adipose tissue lipoprotein lipase. Metabolism 1984, 33:1043-1047.
70. Kahn B.B. Dietary regulation of glucose transporter gene expression: tissue specific effects in adipose cells and muscle. J Nutr 1994, 124:1289S-1295S.
71. Naaz A., Holsberger D.R., Iwamoto G.A., Nelson A., Kiyokawa H., Cooke P.S. Loss of cyclin-dependent kinase inhibitors produces adipocyte hyperplasia and obesity. FASEB J 2004, 18:1925-1927.
72. Amri E.Z., Ailhaud G., Grimaldi P.A. Fatty acids as signal transducing molecules: involvement in the differentiation of preadipose to adipose cells. J Lipid Res 1994, 35:930-937.
73. Bonet M.L., Ribot J., Felipe E., Palou A. Vitamin A and the regulation of fat reserves. Cell Mol Life Sci 2003, 60:1311-1321.
74. Wang Y., Lee-Kwon W., Martindale J.L., Adams L., Heller P., Egan J.M., Bernier M. Modulation of CCAAT/enhancer-binding protein-alpha gene expression by metabolic signals in rodent adipocytes. Endocrinology 1999, 140:2938-2947.
75. Maughan R. The athlete's diet: nutritional goals and dietary strategies. Proc Nutr Soc 2002, 61:87-96.
76. Esmarck B., Andersen J.L., Olsen S., Richter E.A., Mizuno M., Kjaer M. Timing of postexercise protein intake is important for muscle hypertrophy with resistance training in elderly humans. J Physiol 2001, 535:301-311.
77. scientific committee on food (scf), report of the scf on composition and specification of food intended to meet the expenditure of intense muscular effort, especially for sportsmen. scf/cs/nut/sport/5 final 28 february 2001, http://www.europa.eu.int/comm/food/fs/sc/scf/out64_en.pdf.
78. Layman D.K. The role of leucine in weight loss diets and glucose homeostasis. J Nutr 2003, 133:261S-267S.
79. Matthews D.E. Observations of branched-chain amino acid administration in humans. J Nutr 2005, 135:1580S-1584S.
80. Anthony J.C., Anthony T.G., Kimball S.R., Jefferson L.S. Signaling pathways involved in translational control of protein synthesis in skeletal muscle by leucine. J Nutr 2001, 131:856S-860S.
81. Westerterp-Plantenga M.S. Fat intake and energy-balance effects. Physiol Behav 2004, 83:579-585.
82. Duplus E., Glorian M., Forest C. Fatty acid regulation of gene transcription. J Biol Chem 2000, 275:30749-30752.
83. Clarke S.D., Gasperikova D., Nelson C., Lapillonne A., Heird W.C. Fatty acid regulation of gene expression: a genomic explanation for the benefits of the mediterranean diet. Ann N Y Acad Sci 2002, 967:283-298.
84. Jump D.B. Dietary polyunsaturated fatty acids and regulation of gene transcription. Curr Opin Lipidol 2002, 13:155-164.
85. Tao H., Szeszel-Fedorowicz W., Amir-Ahmady B., Gibson M.A., Stabile L.P., Salati L.M. Inhibition of the splicing of glucose-6-phosphate dehydrogenase precursor mRNA by polyunsaturated fatty acids. J Biol Chem 2002, 277:31270-31278.
86. Raclot T., Groscolas R., Langin D., Ferre P. Site-specific regulation of gene expression by n-3 polyunsaturated fatty acids in rat white adipose tissues. J Lipid Res 1997, 38:1963-1972.
87. Flachs P., Horakova O., Brauner P., Rossmeisl M., Pecina P., Franssen-Van Hal N., Ruzickova J., Sponarova J., Drahota Z., Vlcek C., Keijer J., Houstek J., Kopecky J. Polyunsaturated fatty acids of marine origin upregulate mitochondrial biogenesis and induce beta-oxidation in white fat. Diabetologia 2005, 48:2365-2375.
88. Baillie R.A., Takada R., Nakamura M., Clarke S.D. Coordinate induction of peroxisomal acyl-CoA oxidase and UCP-3 by dietary fish oil: a mechanism for decreased body fat deposition. Prostaglandins Leukot Essent Fatty Acids 1999, 60:351-356.
89. Sadurskis A., Dicker A., Cannon B., Nedergaard J. Polyunsaturated fatty acids recruit brown adipose tissue: increased UCP content and NST capacity. Am J Physiol 1995, 269:E351-360.
90. Tsuboyama-Kasaoka N., Takahashi M., Kim H., Ezaki O. Up-regulation of liver uncoupling protein-2 mRNA by either fish oil feeding or fibrate administration in mice. Biochem Biophys Res Commun 1999, 257:879-885.
91. Hun C.S., Hasegawa K., Kawabata T., Kato M., Shimokawa T., Kagawa Y. Increased uncoupling protein2 mRNA in white adipose tissue, and decrease in leptin, visceral fat, blood glucose, and cholesterol in KK-Ay mice fed with eicosapentaenoic and docosahexaenoic acids in addition to linolenic acid. Biochem Biophys Res Commun 1999, 259:85-90.
92. Hu F.B., Manson J.E., Willett W.C. Types of dietary fat and risk of coronary heart disease: a critical review. J Am Coll Nutr 2001, 20:5-19.
93. Brown A.A., Hu F.B. Dietary modulation of endothelial function: implications for cardiovascular disease. Am J Clin Nutr 2001, 73:673-686.
94. Bucher H.C., Hengstler P., Schindler C., Meier G. N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials. Am J Med 2002, 112:298-304.
95. Ailhaud G., Guesnet P. Fatty acid composition of fats is an early determinant of childhood obesity: a short review and an opinion. Obes Rev 2004, 5:21-26.
96. Couet C., Delarue J., Ritz P., Antoine J.M., Lamisse F. Effect of dietary fish oil on body fat mass and basal fat oxidation in healthy adults. Int J Obes Relat Metab Disord 1997, 21:637-643.
97. Summers L.K., Fielding B.A., Bradshaw H.A., Ilic V., Beysen C., Clark M.L., Moore N.R., Frayn K.N. Substituting dietary saturated fat with polyunsaturated fat changes abdominal fat distribution and improves insulin sensitivity. Diabetologia 2002, 45:369-377.
98. Massaro M., De Caterina R. Vasculoprotective effects of oleic acid: epidemiological background and direct vascular antiatherogenic properties. Nutr Metab Cardiovasc Dis 2002, 12:42-51.
99. Lara-Castro C., Garvey W.T. Diet, insulin resistance, and obesity: zoning in on data for Atkins dieters living in South Beach. J Clin Endocrinol Metab 2004, 89:4197-4205.
100. Williams C.M. Beneficial nutritional properties of olive oil: implications for postprandial lipoproteins and factor VII. Nutr Metab Cardiovasc Dis 2001, 11:51-56.
101. Rodriguez V.M., Portillo M.P., Pico C., Macarulla M.T., Palou A. Olive oil feeding up-regulates uncoupling protein genes in rat brown adipose tissue and skeletal muscle. Am J Clin Nutr 2002, 75:213-220.
102. Astrup A. The role of dietary fat in obesity. Semin Vasc Med 2005, 5:40-47.
103. Pieterse Z., Jerling J.C., Oosthuizen W., Kruger H.S., Hanekom S.M., Smuts C.M., Schutte A.E. Substitution of high monounsaturated fatty acid avocado for mixed dietary fats during an energy-restricted diet: effects on weight loss, serum lipids, fibrinogen, and vascular function. Nutrition 2005, 21:67-75.
104. Clifton P.M., Noakes M., Keogh J.B. Very low-fat (12%) and high monounsaturated fat (35%) diets do not differentially affect abdominal fat loss in overweight, nondiabetic women. J Nutr 2004, 134:1741-1745.
105. Pelkman C.L., Fishell V.K., Maddox D.H., Pearson T.A., Mauger D.T., Krisetherton P.M. Effects of moderate-fat (from monounsaturated fat) and low-fat weight-loss diets on the serum lipid profile in overweight and obese men and women. Am J Clin Nutr 2004, 79:204-212.
106. Gumbiner B., Low C.C., Reaven P.D. Effects of a monounsaturated fatty acid-enriched hypocaloric diet on cardiovascular risk factors in obese patients with type 2 diabetes. Diabetes Care 1998, 21:9-15.
107. Papamandjaris A.A., Macdougall D.E., Jones P.J. Medium chain fatty acid metabolism and energy expenditure: obesity treatment implications. Life Sci 1998, 62:1203-1215.
108. St-Onge M.P. Dietary fats, teas, dairy, and nuts: potential functional foods for weight control?. Am J Clin Nutr 2005, 81:7-15.
109. St-Onge M.P., Jones P.J. Physiological effects of medium-chain triglycerides: potential agents in the prevention of obesity. J Nutr 2002, 132:329-332.
110. St-Onge M.P., Ross R., Parsons W.D., Jones P.J. Medium-chain triglycerides increase energy expenditure and decrease adiposity in overweight men. Obes Res 2003, 11:395-402.
111. Portillo M.P., Serra F., Simon E., Del Barrio A.S., Palou A. Energy restriction with high-fat diet enriched with coconut oil gives higher UCP1 and lower white fat in rats. Int J Obes Relat Metab Disord 1998, 22:974-979.
112. Yost T.J., Eckel R.H. Hypocaloric feeding in obese women: metabolic effects of medium-chain triglyceride substitution. Am J Clin Nutr 1989, 49:326-330.
113. Krotkiewski M. Value of VLCD supplementation with medium chain triglycerides. Int J Obes Relat Metab Disord 2001, 25:1393-1400.
114. Tholstrup T., Ehnholm C., Jauhiainen M., Petersen M., Hoy C.E., Lund P., Sandstrom B. Effects of medium-chain fatty acids and oleic acid on blood lipids, lipoproteins, glucose, insulin, and lipid transfer protein activities. Am J Clin Nutr 2004, 79:564-569.
115. Geelen M.J. Medium-chain fatty acids as short-term regulators of hepatic lipogenesis. Biochem J 1994, 302(Pt 1):141-146.
116. Bach A.C., Ingenbleek Y., Frey A. The usefulness of dietary medium-chain triglycerides in body weight control: fact or fancy?. J Lipid Res 1996, 37:708-726.
117. Murata M., Ide T., Hara K. Reciprocal responses to dietary diacylglycerol of hepatic enzymes of fatty acid synthesis and oxidation in the rat. Br J Nutr 1997, 77:107-121.
118. Murase T., Mizuno T., Omachi T., Onizawa K., Komine Y., Kondo H., Hase T., Tokimitsu I. Dietary diacylglycerol suppresses high fat and high sucrose diet-induced body fat accumulation in C57BL/6J mice. J Lipid Res 2001, 42:372-378.
119. Tada N. Physiological actions of diacylglycerol outcome. Curr Opin Clin Nutr Metab Care 2004, 7:145-149.
120. Taguchi H., Watanabe H., Onizawa K., Nagao T., Gotoh N., Yasukawa T., Tsushima R., Shimasaki H., Itakura H. Double-blind controlled study on the effects of dietary diacylglycerol on postprandial serum and chylomicron triacylglycerol responses in healthy humans. J Am Coll Nutr 2000, 19:789-796.
121. Kamphuis M.M., Mela D.J., Westerterp-Plantenga M.S. Diacylglycerols affect substrate oxidation and appetite in humans. Am J Clin Nutr 2003, 77:1133-1139.
122. Nagao T., Watanabe H., Goto N., Onizawa K., Taguchi H., Matsuo N., Yasukawa T., Tsushima R., Shimasaki H., Itakura H. Dietary diacylglycerol suppresses accumulation of body fat compared to triacylglycerol in men in a double-blind controlled trial. J Nutr 2000, 130:792-797.
123. Maki K.C., Davidson M.H., Tsushima R., Matsuo N., Tokimitsu I., D Umporowicz M., Dicklin M.R., Foster G.S., Ingram K.A., Anderson B.D., Frost S.D., Bell M. Consumption of diacylglycerol oil as part of a reduced-energy diet enhances loss of body weight and fat in comparison with consumption of a triacylglycerol control oil. Am J Clin Nutr 2002, 76:1230-1236.
124. Tomonobu K., Hase T., Tokimitsu I. Dietary diacylglycerol in a typical meal suppresses postprandial increases in serum lipid levels compared with dietary triacylglycerol. Nutrition 2006, 22:128-135.
125. Saito S., Tomonobu K., Hase T., Tokimitsu I. Effects of diacylglycerol on postprandial energy expenditure and respiratory quotient in healthy subjects. Nutrition 2006, 22:30-35.
126. Yamamoto K., Takeshita M., Tokimitsu I., Watanabe H., Mizuno T., Asakawa H., Tokunaga K., Tatsumi T., Okazaki M., Yagi N. Diacylglycerol oil ingestion in type 2 diabetic patients with hypertriglyceridemia. Nutrition 2006, 22:23-29.
127. Takase H., Shoji K., Hase T., Tokimitsu I. Effect of diacylglycerol on postprandial lipid metabolism in non-diabetic subjects with and without insulin resistance. Atherosclerosis 2005, 180:197-204.
128. Flickinger B.D., Matsuo N. Nutritional characteristics of DAG oil. Lipids 2003, 38:129-132.
129. Westerterp-Plantenga M.S., Lejeune M.P. Protein intake and body-weight regulation. Appetite 2005, 45:187-190.
130. Nickols-Richardson S.M., Coleman M.D., Volpe J.J., Hosig K.W. Perceived hunger is lower and weight loss is greater in overweight premenopausal women consuming a low-carbohydrate/high-protein vs high-carbohydrate/low-fat diet. J Am Diet Assoc 2005, 105:1433-1437.
131. Westerterp-Plantenga M.S., Lejeune M.P., Nijs I., Van Ooijen M., Kovacs E.M. High protein intake sustains weight maintenance after body weight loss in humans. Int J Obes Relat Metab Disord 2004, 28:57-64.
132. Layman D.K., Boileau R.A., Erickson D.J., Painter J.E., Shiue H., Sather C., Christou D.D. A reduced ratio of dietary carbohydrate to protein improves body composition and blood lipid profiles during weight loss in adult women. J Nutr 2003, 133:411-417.
133. Layman D.K., Baum J.I. Dietary protein impact on glycemic control during weight loss. J Nutr 2004, 134:968S-973S.
134. Eisenstein J., Roberts S.B., Dallal G., Saltzman E. High-protein weight-loss diets: are they safe and do they work? A review of the experimental and epidemiologic data. Nutr Rev 2002, 60:189-200.
135. Hu F.B., Stampfer M.J., Manson J.E., Rimm E., Colditz G.A., Speizer F.E., Hennekens C.H., Willett W.C. Dietary protein and risk of ischemic heart disease in women. Am J Clin Nutr 1999, 70:221-227.
136. Iso H, Stampfer M J, Manson J E, Rexrode K, Hu F, Hennekens C H, Colditz G A, Speizer F E and Willett W C, prospective study of fat and protein intake and risk of intraparenchymal hemorrhage in women, Circulation 103, 856-863.
137. Noakes M., Keogh J.B., Foster P.R., Clifton P.M. Effect of an energyrestricted, high-protein, low-fat diet relative to a conventional high-carbohydrate, low-fat diet on weight loss, body composition, nutritional status, and markers of cardiovascular health in obese women. Am J Clin Nutr 2005, 81:1298-1306.
138. Zemel M.B. Role of calcium and dairy products in energy partitioning and weight management. Am J Clin Nutr 2004, 79:907S-912S.
139. Barr S.I. Increased dairy product or calcium intake: is body weight or composition affected in humans?. J Nutr 2003, 133:245S-248S.
140. Heaney R.P., Davies K.M., Barger-Lux M.J. Calcium and weight: clinical studies. J Am Coll Nutr 2002, 21:152S-155S.
141. Zemel M.B., Thompson W., Milstead A., Morris K., Campbell P. Calcium and dairy acceleration of weight and fat loss during energy restriction in obese adults. Obes Res 2004, 12:582-590.
142. Zemel M.B., Richards J., Milstead A., Campbell P. Effects of calcium and dairy on body composition and weight loss in African-American adults. Obes Res 2005, 13:1218-1225.
143. Zemel M.B., Richards J., Mathis S., Milstead A., Gebhardt L., Silva E. Dairy augmentation of total and central fat loss in obese subjects. Int J Obes (Lond) 2005, 29:391-397.
144. Bowen J., Noakes M., Clifton P.M. A high dairy protein, high-calcium diet minimizes bone turnover in overweight adults during weight loss. J Nutr 2004, 134:568-573.
145. Shapses S.A., Heshka S., Heymsfield S.B. Effect of calcium supplementation on weight and fat loss in women. J Clin Endocrinol Metab 2004, 89:632-637.
146. Thompson W.G., Rostad Holdman N., Janzow D.J., Slezak J.M., Morris K.L., Zemel M.B. Effect of energy-reduced diets high in dairy products and fiber on weight loss in obese adults. Obes Res 2005, 13:1344-1353.
147. Parikh S.J., Yanovski J.A. Calcium intake and adiposity. Am J Clin Nutr 2003, 77:281-287.
148. Puigserver P., VÁZquez F., Bonet M.L., Picó C., Palou A. In vitro and in vivo induction of brown adipocyte uncoupling protein (thermogenin) by retinoic acid. Biochem J 1996, 317:827-833.
149. Bonet M.L., Oliver J., Picó C., Felipe F., Ribot J., Cinti S., Palou A. Opposite effects of vitamin A deficient diet-feeding and retinoic acid treatment on brown adipose tissue UCP1, UCP2 and leptin expression. J. Endocrinol 2000, 166:511-517.
150. Ribot J., Felipe F., Bonet M.L., Palou A. Changes of adiposity in response to vitamin A status correlate with changes of PPAR gamma 2 expression. Obes Res 2001, 9:500-509.
151. Mercader J., Ribot J., Murano I., Felipe F., Cinti S., Bonet M.L., Palou A. Remodeling of white adipose tissue after retinoic acid administration in mice. Endocrinology 2006, 147:5325-5332.
152. Serra F., Bonet M.L., Puigserver P., Oliver J., Palou A. Stimulation of uncoupling protein 1 expression in brown adipocytes by naturally occurring carotenoids. Int J Obes Relat Metab Disord 1999, 23:650-655.
153. Felipe F., Bonet M.L., Ribot J., Palou A. Up-regulation of muscle uncoupling protein 3 gene expression in mice following high fat diet, dietary vitamin A supplementation and acute retinoic acid-treatment. Int J Obes Relat Metab Disord 2003, 27:60-69.
154. Kumar M.V., Sunvold G.D., Scarpace P.J. Dietary vitamin A supplementation in rats: suppression of leptin and induction of UCP1 mRNA. J Lipid Res 1999, 40:824-829.
155. Kawada T., Kamei Y., Sugimoto E. The possibility of active form of vitamin A and D as supressors on adipocyte development via ligand-dependent transcriptional regulators. Int J Obes Relat Metab Disord 1996, 20:S52-S57.
156. Felipe F., Bonet M.L., Ribot J., Palou A. Modulation of resistin expression by retinoic acid and vitamin A status. Diabetes 2004, 53:882-889.
157. Kumar M.V., Scarpace P.J. Differential effects of retinoic acid on uncoupling protein-1 and leptin gene expression. J Endocrinol 1998, 157:237-243.
158. Felipe F., Mercader J., Ribot J., Palou A., Bonet M.L. Effects of retinoic acid administration and dietary vitamin A supplementation on leptin expression in mice: lack of correlation with changes of adipose tissue mass and food intake. Biochim Biophys Acta 2005, 1740:258-265.
159. Wolfe W.S., Sanjur D. Contemporary diet and body weight of Navajo women receiving food assistance: an ethnographic and nutritional investigation. J Am Diet Assoc 1988, 88:822-827.
160. Vaughan L.A., Benyshek D.C., Martin J.F. Food acquisition habits, nutrient intakes, and anthropometric data of Havasupai adults. J Am Diet Assoc 1997, 97:1275-1282.
161. Stephens D., Jackson P.L., Gutierrez Y. Subclinical vitamin A deficiency: a potentially unrecognized problem in the United States. Pediatr Nurs 1996, 22:377-389. 456.
162. Andraws R., Chawla P., Brown D.L. Cardiovascular effects of ephedra alkaloids: a comprehensive review. Prog Cardiovasc Dis 2005, 47:217-225.
163. Shekelle P.G., Hardy M.L., Morton S.C., Maglione M., Mojica W.A., Suttorp M.J., Rhodes S.L., Jungvig L., Gagne J. Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: a meta-analysis. JAMA 2003, 289:1537-1545.
164. Dulloo A.G. Herbal simulation of ephedrine and caffeine in treatment of obesity. Int J Obes Relat Metab Disord 2002, 26:590-592.
165. Greenway F.L. The safety and efficacy of pharmaceutical and herbal caffeine and ephedrine use as a weight loss agent. Obes Rev 2001, 2:199-211.
166. Haller C.A., Benowitz N.L. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. N Engl J Med 2000, 343:1833-1838.
167. Gougeon R., Harrigan K., Tremblay J.F., Hedrei P., Lamarche M., Morais J.A. Increase in the thermic effect of food in women by adrenergic amines extracted from citrus aurantium. Obes Res 2005, 13:1187-1194.
168. Carpene C., Galitzky J., Fontana E., Atgie C., Lafontan M., Berlan M. Selective activation of beta3-adrenoceptors by octopamine: comparative studies in mammalian fat cells. Naunyn Schmiedebergs Arch Pharmacol 1999, 359:310-321.
169. Fugh-Berman A., Myers A. Citrus aurantium, an ingredient of dietary supplements marketed for weight loss: current status of clinical and basic research. Exp Biol Med (Maywood) 2004, 229:698-704.
170. Bent S., Padula A., Neuhaus J. Safety and efficacy of citrus aurantium for weight loss. Am J Cardiol 2004, 94:1359-1361.
171. Dulloo A.G., Duret C., Rohrer D., Girardier L., Mensi N., Fathi M., Chantre P., Vandermander J. Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans. Am J Clin Nutr 1999, 70:1040-1045.
172. Chantre P., Lairon D. Recent findings of green tea extract AR25 (Exolise) and its activity for the treatment of obesity. Phytomedicine 2002, 9:3-8.
173. Rumpler W., Seale J., Clevidence B., Judd J., Wiley E., Yamamoto S., Komatsu T., Sawaki T., Ishikura Y., Hosoda K. Oolong tea increases metabolic rate and fat oxidation in men. J Nutr 2001, 131:2848-2852.
174. Komatsu T., Nakamori M., Komatsu K., Hosoda K., Okamura M., Toyama K., Ishikura Y., Sakai T., Kunii D., Yamamoto S. Oolong tea increases energy metabolism in Japanese females. J Med Invest 2003, 50:170-175.
175. Ohnuki K., Niwa S., Maeda S., Inoue N., Yazawa S., Fushiki T. CH-19 sweet, a non-pungent cultivar of red pepper, increased body temperature and oxygen consumption in humans. Biosci Biotechnol Biochem 2001, 65:2033-2036.
176. Ohnuki K., Haramizu S., Oki K., Watanabe T., Yazawa S., Fushiki T. Administration of capsiate, a non-pungent capsaicin analog, promotes energy metabolism and suppresses body fat accumulation in mice. Biosci Biotechnol Biochem 2001, 65:2735-2740.
177. Henry C.J., Emery B. Effect of spiced food on metabolic rate. Hum Nutr Clin Nutr 1986, 40:165-168.
178. Yoshioka M., St-Pierre S., Suzuki M., Tremblay A. Effects of red pepper added to high-fat and high-carbohydrate meals on energy metabolism and substrate utilization in Japanese women. Br J Nutr 1998, 80:503-510.
179. Matsumoto T., Miyawaki C., Ue H., Yuasa T., Miyatsuji A., Moritani T. Effects of capsaicin-containing yellow curry sauce on sympathetic nervous system activity and diet-induced thermogenesis in lean and obese young women. J Nutr Sci Vitaminol (Tokyo) 2000, 46:309-315.
180. Tsuda T., Horio F., Uchida K., Aoki H., Osawa T. Dietary cyanidin 3-O-beta-D-glucoside-rich purple corn color prevents obesity and ameliorates hyperglycemia in mice. J Nutr 2003, 133:2125-2130.
181. Jena B.S., Jayaprakasha G.K., Singh R.P., Sakariah K.K. Chemistry and biochemistry of (-)-hydroxycitric acid from. Garcinia, J Agric Food Chem 2002, 50:10-22.
182. Pittler M.H., Ernst E. Dietary supplements for body-weight reduction: a systematic review. Am J Clin Nutr 2004, 79:529-536.
183. Saper R.B., Eisenberg D.M., Phillips R.S. Common dietary supplements for weight loss. Am Fam Physician 2004, 70:1731-1738.
184. Preuss H.G., Garis R.I., Bramble J.D., Bagchi D., Bagchi M., Rao C.V., Satyanarayana S. Efficacy of a novel calcium/potassium salt of (-)-hydroxycitric acid in weight control. Int J Clin Pharmacol Res 2005, 25:133-144.
185. Garcia-Pelaez B., Ferrer-Lorente R., Gomez-Olles S., Fernandez-Lopez J.A., Remesar X., Alemany M. Technical note: Measurement of total estrone content in foods. Application to dairy products. J Dairy Sci 2004, 87:2331-2336.
186. Sanchis D., Balada F., Del Mar Grasa M., Virgili J., Peinado J., Monserrat C., Fernandez-Lopez J.A., Remesar X., Alemany M. Oleoyl-estrone induces the loss of body fat in rats. Int J Obes Relat Metab Disord 1996, 20:588-594.
187. Grasa M.M., Vila R., Esteve M., Cabot C., Fernandez-Lopez J.A., Remesar X., Alemany M. Oleoyl-estrone lowers the body weight of both ob/ob and db/db mice. Horm Metab Res 2000, 32:246-250.
188. Remesar X., Guijarro P., Torregrosa C., Grasa M.M., Lopez J., Fernandez-Lopez J.A., Alemany M. Oral oleoyl-estrone induces the rapid loss of body fat in Zucker lean rats fed a hyperlipidic diet. Int J Obes Relat Metab Disord 2000, 24:1405-1412.
189. Sanchis D., Balada F., Pico C., Grasa M.M., Virgili J., Farrerons C., Palou A., Fernandez-Lopez J.A., Remesar X., Alemany M. Rats receiving the slimming agent oleoyl-estrone in liposomes (Merlin-2) decrease food intake but maintain thermogenesis. Arch Physiol Biochem 1997, 105:663-672.
190. Alemany M., Fernandez-Lopez J.A., Petrobelli A., Granada M., Foz M., Remesar X. [Weight loss in a patient with morbid obesity under treatment with oleoyl-estrone]. Med Clin (Barc) 2003, 121:496-499.
191. Mccarthy A.A. When enough is too much: new strategies to treat obesity. Chem Biol 2004, 11:1025-1026.
192. Claret M., Corominola H., Canals I., Saura J., Barcelo-Batllori S., Guinovart J.J., Gomis R. Tungstate decreases weight gain and adiposity in obese rats through increased thermogenesis and lipid oxidation. Endocrinology 2005, 146:4362-4369.
193. Andersen T., Fogh J. Weight loss and delayed gastric emptying following a South American herbal preparation in overweight patients. J Hum Nutr Diet 2001, 14:243-250.
194. Nakagawa K., Kishida H., Arai N., Nishiyama T., Mae T. Licorice flavonoids suppress abdominal fat accumulation and increase in blood glucose level in obese diabetic KK-A(y) mice. Biol Pharm Bull 2004, 27:1775-1778.
195. Armanini D., De Palo C.B., Mattarello M.J., Spinella P., Zaccaria M., Ermolao A., Palermo M., Fiore C., Sartorato P., Francini-Pesenti F., Karbowiak I. Effect of licorice on the reduction of body fat mass in healthy subjects. J Endocrinol Invest 2003, 26:646-650.
196. Graham T.E. Caffeine and exercise: metabolism, endurance and performance. Sports Med 2001, 31:785-807.
197. Magkos F., Kavouras S.A. Caffeine and ephedrine: physiological, metabolic and performance-enhancing effects. Sports Med 2004, 34:871-889.
198. Keisler B.D., Hosey R.G. Ergogenic aids: an update on ephedra. Curr Sports Med Rep 2005, 4:231-235.
199. Nissen S.L., Sharp R.L. Effect of dietary supplements on lean mass and strength gains with resistance exercise: a meta-analysis. J Appl Physiol 2003, 94:651-659.
200. Pariza M.W. Perspective on the safety and effectiveness of conjugated linoleic acid. Am J Clin Nutr 2004, 79:1132S-1136S.
201. Larsen T.M., Toubro S., Astrup A. Efficacy and safety of dietary supplements containing CLA for the treatment of obesity: evidence from animal and human studies. J Lipid Res 2003, 44:2234-2241.
202. Rodriguez E., Ribot J., Palou A. Trans-10, cis-12, but not cis-9, trans-11 CLA isomer, inhibits brown adipocyte thermogenic capacity. Am J Physiol Regul Integr Comp Physiol 2002, 282:R1789-1797.
203. Pariza M.W., Park Y., Cook M.E. The biologically active isomers of conjugated linoleic acid. Prog Lipid Res 2001, 40:283-298.
204. Rainer L., Heiss C.J. Conjugated linoleic acid: health implications and effects on body composition. J Am Diet Assoc 2004, 104:963-968. quiz 1032.
205. Wang Y., Jones P.J. Dietary conjugated linoleic acid and body composition. Am J Clin Nutr 2004, 79:1153S-1158S.
206. Wang Y.W., Jones P.J. Conjugated linoleic acid and obesity control: efficacy and mechanisms. Int J Obes Relat Metab Disord 2004, 28:941-955.
207. Terpstra A.H. Effect of conjugated linoleic acid on body composition and plasma lipids in humans: an overview of the literature. Am J Clin Nutr 2004, 79:352-361.
208. Gaullier J.M., Halse J., Hoye K., Kristiansen K., Fagertun H., Vik H., Gudmundsen O. Conjugated linoleic acid supplementation for 1 y reduces body fat mass in healthy overweight humans. Am J Clin Nutr 2004, 79:1118-1125.
209. Gaullier J.M., Halse J., Hoye K., Kristiansen K., Fagertun H., Vik H., Gudmundsen O. Supplementation with conjugated linoleic acid for 24 months is well tolerated by and reduces body fat mass in healthy, overweight humans. J Nutr 2005, 135:778-784.
210. Kamphuis M.M., Lejeune M.P., Saris W.H., Westerterp-Plantenga M.S. The effect of conjugated linoleic acid supplementation after weight loss on body weight regain, body composition, and resting metabolic rate in overweight subjects. Int J Obes Relat Metab Disord 2003, 27:840-847.
211. Riserus U., Smedman A., Basu S., Vessby B. Metabolic effects of conjugated linoleic acid in humans: the Swedish experience. Am J Clin Nutr 2004, 79:1146S-1148S.
212. Whigham L.D., O'shea M., Mohede I.C., Walaski H.P., Atkinson R.L. Safety profile of conjugated linoleic acid in a 12-month trial in obese humans. Food Chem Toxicol 2004, 42:1701-1709.
213. Vincent J.B. The potential value and toxicity of chromium picolinate as a nutritional supplement, weight loss agent and muscle development agent. Sports Med 2003, 33:213-230.
214. Pittler M.H., Stevinson C., Ernst E. Chromium picolinate for reducing body weight: meta-analysis of randomized trials. Int J Obes Relat Metab Disord 2003, 27:522-529.
215. Kleefstra N., Houweling S.T., Jansman F.G., Groenier K.H., Gans R.O., Meyboomde Jong B., Bakker S.J., Bilo H.J. Chromium treatment has no effect in patients with poorly controlled, insulin-treated type 2 diabetes in an obese Western population: a randomized, double-blind, placebo-controlled trial. Diabetes Care 2006, 29:521-525.
216. Nissen S., Sharp R., Ray M., Rathmacher J.A., Rice D., Fuller J.C., Connelly A.S., Abumrad N. Effect of leucine metabolite beta-hydroxy-beta-methylbutyrate on muscle metabolism during resistance-exercise training. J Appl Physiol 1996, 81:2095-2104.
217. Knitter A.E., Panton L., Rathmacher J.A., Petersen A., Sharp R. Effects of beta-hydroxy-beta-methylbutyrate on muscle damage after a prolonged run. J Appl Physiol 2000, 89:1340-1344.
218. Tokish J.M., Kocher M.S., Hawkins R.J. Ergogenic aids: a review of basic science, performance, side effects, and status in sports. Am J Sports Med 2004, 32:1543-1553.
219. Karlic H., Lohninger A. Supplementation of L-carnitine in athletes: does it make sense?. Nutrition 2004, 20:709-715.
220. Barnett C., Costill D.L., Vukovich M.D., Cole K.J., Goodpaster B.H., Trappe S.W., Fink W.J. Effect of L-carnitine supplementation on muscle and blood carnitine content and lactate accumulation during high-intensity sprint cycling. Int J Sport Nutr 1994, 4:280-288.
221. Villani R.G., Gannon J., Self M., Rich P.A. l-Carnitine supplementation combined with aerobic training does not promote weight loss in moderately obese women. Int J Sport Nutr Exerc Metab 2000, 10:199-207.
222. Hahn A., Strohle A., Wolters M. [Dietary supplements and functional food for weight reduction - expectations and reality]. MMW Fortschr Med 2003, 145:40-45.
223. Bray G.A. Low-carbohydrate diets and realities of weight loss. JAMA 2003, 289:1853-1855.
224. Bell S.J., Goodrick G.K. A functional food product for the management of weight. Crit Rev Food Sci Nutr 2002, 42:163-178.